Mycophenolate Mofetil and Abacavir Treatment in HIV Patients With Failed Anti-HIV Treatment

NCT00021489 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Abacavir sulfate
DRUG: Mycophenolate mofetil

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)